cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.u5gzjl
title: Occurrence Download

description: A dataset containing 2629 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Mexico",
 "TaxonKey is Abies Mill."
 ]
}

 The dataset includes 2629 records from 89 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014973-171219132708484/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dx2nv5
title: Occurrence Download

description: A dataset containing 254 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "or" : [
 "Country is China",
 "Country is Nepal",
 "Country is India",
 "Country is Bhutan",
 "Country is Myanmar"
 ]
 },
 "TaxonKey is Ligularia hookeri (C.B.Clarke) Hand.-Mazz."
 ]
}

 The dataset includes 254 records from 27 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0017974-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.lgbj30
title: Occurrence Download

description: A dataset containing 17550 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bombus vosnesenskii Radoszkowski, 1862"
 ]
}

 The dataset includes 17550 records from 41 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0032193-190415153152247/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.f5jfaf
title: Occurrence Download

description: A dataset containing 187 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cordylostigma longifolium (Klotzsch) Groeninckx & Dessein"
 ]
}

 The dataset includes 187 records from 19 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014975-181003121212138/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.5yg8jv
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "ScientificName" : [
 "is one of (Valeriana boelckei, Valeriana carnosa, Valeriana chilensis, Valeriana clarionifolia, Valeriana corynodes, Valeriana crispa, Valeriana effusa, Valeriana fonkii, Valeriana gracilipes, Valeriana grandifolia, Valeriana hebecarpa, Valeriana hornschuchiana, Valeriana lapathifolia, Valeriana laxiflora, Valeriana lepidota, Valeriana leucocarpa, Valeriana lobata, Valeriana macrorhiza, Valeriana magellanicasedifolia, Valeriana moyanoi, Valeriana nivalis, Valeriana philippiana, Valeriana polemoniifolia, Valeriana polybotrya, Valeriana polystachya, Valeriana radicalis, Valeriana stricta, Valeriana stuckertii, Valeriana vaga, Valeriana verticillata, Valeriana virescens)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0017097-210914110416597/datasets/export for details.
DOI: 10.15468/dl.tj2frp
title: Occurrence Download

description: A dataset containing 174 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Meconopsis punicea Maxim."
 ]
}

 The dataset includes 174 records from 23 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0008315-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.milqqo
title: Occurrence Download

description: A dataset containing 386 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ephedra equisetina Bunge"
 ]
}

 The dataset includes 386 records from 40 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014976-190918142434337/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wwbije
title: Occurrence Download

description: A dataset containing 979 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Tovariaceae"
 ]
}

 The dataset includes 979 records from 68 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000481-180508205500799/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.en8v7b
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is United Arab Emirates",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Rhina ancylostoma Bloch & Schneider, 1801"
 ]
}

 The dataset includes 4 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0017968-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.uiz7sk
title: Occurrence Download

description: A dataset containing 1219 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Oreothlypis crissalis (Salvin & Godman, 1889)"
 ]
}

 The dataset includes 1219 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014981-160910150852091/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.24gkuc
title: Occurrence Download

description: A dataset containing 18868 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Puma Jardine, 1834"
 ]
}

 The dataset includes 18868 records from 304 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0065846-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.g5sm3f
title: Occurrence Download

description: A dataset containing 283 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Callosobruchus chinensis (Linnaeus, 1758)"
 ]
}

 The dataset includes 283 records from 47 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0027437-191105090559680/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wp4xak
title: Occurrence Download

description: A dataset containing 306 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Hypopachus variolosus (Cope, 1866)",
 "Country is United States of America"
 ]
}

 The dataset includes 306 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014983-160118175350007/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.f4j3ud
title: Occurrence Download

description: A dataset containing 1733376 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Specimen",
 "Country is Colombia",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 1733376 records from 1283 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012859-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.4hkym8
title: Occurrence Download

description: A dataset containing 19 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ceiba pentandra",
 "Country is South Africa",
 "HasCoordinate is true"
 ]
}

 The dataset includes 19 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0045697-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.zhfg5g
title: Occurrence Download

description: A dataset containing 2 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ceiba pentandra",
 "Country is Solomon Islands",
 "HasCoordinate is true"
 ]
}

 The dataset includes 2 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0045696-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3886/e204701v2-187865
title: Data and Code for: Health, Health Insurance, and Inequality

description: This paper identifies a “health premium” of
insurance coverage: insured individuals are more likely to maintain good health
or recover from poor health. We introduce this feature into a prototypical
macro-health model and estimate the baseline economy by matching the observed
joint distribution of health insurance, health, and income over the life cycle.
Quantitative analysis reveals that an individual’s insurance status has a
substantial and persistent impact on health. Providing universal health
coverage would narrow health and life expectancy gaps, with a mixed effect on
the income distribution in the absence of any additional redistribution of income
or wealth.
DOI: 10.5281/zenodo.17086459
title: Pickleball_gender_Asymmetries
DOI: 10.15468/dl.m2sm8b
title: Occurrence Download

description: A dataset containing 2 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ceiba pentandra",
 "Country is Tonga",
 "HasCoordinate is true"
 ]
}

 The dataset includes 2 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0045698-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3535/vz3-c92-fpb
title: Acrocordia conoidea (Fr.) Körb.

description: Digital Specimen for the physical specimen hosted at University of Graz.
DOI: 10.25934/pr00011654
title: An Open-Label Pilot Study of Pioglitazone in Sporadic Inclusion Body Myositis

description: A study looking at the effect of pioglitazone in skeletal muscle of patients with sporadic inclusion body myositis (sIBM).
DOI: 10.25934/pr00011554
title: A Phase 3, Multicenter, Randomized, Double-Blind Study With an Active-Controlled Initial Treatment Period Followed by a Dose-Blind Maintenance Treatment Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

description: This is a study to compare the efficacy of bimekizumab versus adalimumab in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).
DOI: 10.25934/pr00011555
title: A Multicenter, Randomized, Double-Blind, Secukinumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

description: This is a study to compare the efficacy of bimekizumab versus secukinumab in subjects with moderate to severe chronic plaque psoriasis (PSO).
DOI: 10.25934/pr00011556
title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

description: This is a study to compare the efficacy of bimekizumab versus placebo and an active comparator in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).
DOI: 10.25934/pr00011565
title: A Randomized, Active-comparator, Observer-blind, Phase I/II/III Study to Demonstrate the Immunogenicity of a Single Booster Dose of DS-5670a in Adults and Elderly Received a Primary Series of Approved COVID-19 Vaccine

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/pr00011566
title: A Phase 3, Randomized, Active-controlled, Observer-blinded, Non-inferiority Study to Evaluate the Safety and Immunogenicity of Booster Immunization with DS-5670a/b (Bivalent: Original Strain/Omicron Strain BA.4-5) in Subjects Aged 12 Years and Older Who Have Completed Initial and Booster Immunization with SARS-CoV-2 Vaccines

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/pr00011567
title: A phase III, randomized, active-comparator, observer-blind, non-inferiority study to demonstrate the immunogenicity and safety of DS-5670d (monovalent: omicron XBB.1.5) in adults and children aged 12 years and older

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/pr00011574
title: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

description: This prospective annual release study was designed to assess the safety of a trivalent influenza virus vaccine using two new strains recommended for the 2012-2013 influenza season not previously contained in the trivalent intranasal FluMist vaccine.Three hundred healthy adults will receive a single dose of vaccine or placebo and will be followed for 180 days after study vaccination.
DOI: 10.25934/pr00011575
title: Phase II, Open Label, Single-arm Study to Assess Safety and Efficacy of AZD9291 in Patients With Locally Advanced/Metastatic NSCLC Whose Disease Has Progressed With Previous EGFR TKI and Whose Tumours Are EGFR and T790M Mutation Positive

description: A Phase II, Open Label, Single-arm Study to Assess the Safety and Efficacy of AZD9291 in Patients with Locally Advanced/Metastatic Non Small Cell Lung Cancer whose Disease has Progressed with Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and whose Tumours are Epidermal Growth Factor Receptor Mutation and T790M Mutation Positive
DOI: 10.25934/pr00011576
title: A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Inadequately Controlled, Severe Asthma

description: The primary objective of the study is to evaluate the effect of 3 dose levels of MEDI9929 (AMG 157) on asthma exacerbations in adult subjects with inadequately controlled, severe asthma.
DOI: 10.25934/pr00011577
title: A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

description: To evaluate the PK profile of a single-dose of 140 mg subcutaneous (SC) administration of MEDI9929 (AMG 157) in adolescent subjects with mild to moderate asthma.
DOI: 10.25934/pr00011578
title: A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents With Severe Uncontrolled Asthma (NAVIGATOR)

description: A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma
DOI: 10.25934/pr00011579
title: A Multicentre, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma (SOURCE)

description: Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma
DOI: 10.3535/7ya-lq0-q87
title: Bagliettoa parmigerella (Zahlbr.) Vězda & Poelt

description: Digital Specimen for the physical specimen hosted at University of Graz.
DOI: 10.25934/pr00011580
title: A Multicenter, Randomized, Open-label, Parallel Group, Functionality, and Performance Study of an Accessorized Pre-filled Syringe and Autoinjector With Home-administered Subcutaneous Tezepelumab in Adolescent and Adult Subjects With Severe Asthma (PATH-HOME)

description: This is a multicenter, randomized, open-label, parallel-group study designed to assess healthcare provider and subject/caregiver reported functionality and performance of a single-use accessorized pre-filled syringe (APFS) or autoinjector (AI) with a fixed 210 mg dose of tezepelumab administered subcutaneously in the clinic and in an at-home setting.
DOI: 10.25934/pr00011581
title: An Open Label, Randomized, Parallel Group Study to Evaluate the Pharmacokinetics of Tezepelumab Administered Subcutaneously Via Accessorized Pre Filled Syringe (APFS) or Autoinjector (AI) Compared With Vial and Syringe in Healthy Adult Subjects (PATH-BRIDGE)

description: This is a study to compare PK of tezepelumab exposure in healthy subjects by using vial and syringe, APFS, and AI.
DOI: 10.25934/pr00011582
title: A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults With Inadequately Controlled Asthma on Inhaled Corticosteroids and at Least One Additional Asthma Controller (CASCADE)

description: A phase 2, multicentre, randomized, double-blind, placebo-controlled, parallel group study to evaluate the effect of tezepelumab on airway inflammation in adults with inadequately controlled asthma.
DOI: 10.25934/pr00011583
title: A Multicentre, Double-blind, Randomized, Placebo Controlled, Parallel Group, Phase 3, Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe Uncontrolled Asthma (DESTINATION)

description: Subjects who completed either D5180C00007 or D5180C00009 will be offered the opportunity to consent for the Multicentre, Double-blind, Randomized, Placebo Controlled, Parallel Group, Phase 3, Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma. The study consists of a treatment phase, followed by a follow-up phase where subjects will not receive IP. The length of the follow up phase is determined by which study the subject had previously completed.
DOI: 10.25934/pr00011584
title: A 52-Week, Open-Label, Multicentre Study to Evaluate the Safety of Tezepelumab in Japanese Adults and Adolescents With Inadequately Controlled Severe Asthma (NOZOMI)

description: This is an open-label, single arm study designed to evaluate the safety of tezepelumab administered subcutaneously every 4 weeks in Japanese adult and adolescent subjects with inadequately controlled severe asthma.
DOI: 10.25934/pr00011585
title: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Adolescent and Young Adult Participants With Moderate to Severe Asthma (VECTOR)

description: This is a Phase 3b, multicenter, randomized, double-blind, parallel group, placebo-controlled study designed to investigate the potential effect of tezepelumab (210 mg subcutaneous \[SC\] every 4 weeks \[Q4W\]) on antibody responses following seasonal quadrivalent influenza virus vaccination in the fall/winter 2021-2022 in the USA.
DOI: 10.25934/pr00011586
title: A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis

description: To assess the efficacy and safety of MEDI9929 in adult subjects with Atopic Dermatitis
DOI: 10.25934/pr00011587
title: A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) (COURSE)

description: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
DOI: 10.25934/pr00011588
title: A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)

description: The study is a randomized, double-blind, placebo-controlled (corn oil), parallel group design that will enroll approximately 13,000 patients with hypertriglyceridemia and low HDL and high risk for CVD to be randomized 1:1 to either corn oil + statin or Epanova + statin, once daily, for approximately 3-5 years as determined when the number of MACE outcomes is reached.
DOI: 10.25934/pr00011589
title: A 6-Week, Randomized, Double-Blind, Placebo(Olive Oil)-Controlled Study to Assess the Efficacy and Safety of Add-On Epanova® to Statin Therapy in Subjects With Persistent Hypertriglyceridemia and High Risk for Cardiovascular Disease

description: The primary objective is to evaluate the efficacy of adding Epanova (2 g or 4 g daily) to an optimal statin monotherapy for lowering non-high-density lipoprotein (non-HDL) cholesterol in subjects with persistent hypertriglyceridemia and high risk for cardiovascular disease.
DOI: 10.25934/pr00011590
title: A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19.

description: This study will assess the safety and efficacy of a single dose of AZD7442(× 2 IM injections) compared to placebo for the prevention of COVID-19.
DOI: 10.25934/pr00011591
title: A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19

description: This study will assess the efficacy of AZD7442 for the post-exposure prophylaxis of COVID-19 in Adults.
DOI: 10.25934/pr00011592
title: A Phase II Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

description: To evaluate the safety and tolerability of a single dose of 600 mg AZD7442 administered IV (intravenous) to Chinese adults (including those with stable medical conditions).